Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Crespo

Showing results (281-290 of 365) with videos related to

Pageof 37
Sort By:
Annals of Hepatology|May 29, 2015
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in SpainJavier Crespo, Moisés Diago, Joaquín Cabezas, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Journal of Clinical Gastroenterology|June 23, 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE StudySonia Rodríguez-Nóvoa, Javier García-Samaniego, Martín Prieto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.
Digestive Diseases and Sciences|January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular CarcinomaMar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2024
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseasesEnrique García-Nieto, Juan Carlos Rodriguez-Duque, Coral Rivas-Rivas, et al.
Nature Communications|May 9, 2017
Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.
Journal of Viral Hepatitis|March 3, 2026
Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence SynthesisChristos Thomadakis, Ilias Gountas, Konstantinos Gountas, et al.
Nature Communications|June 17, 2017
Corrigendum: Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Pageof 37

Showing results (281-290 of 365) with videos related to

Sort By:
Pageof 37
Annals of Hepatology|May 29, 2015
High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in SpainJavier Crespo, Moisés Diago, Joaquín Cabezas, et al.
Scientific Reports|August 13, 2016
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver diseaseRocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, et al.
Journal of Clinical Gastroenterology|June 23, 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE StudySonia Rodríguez-Nóvoa, Javier García-Samaniego, Martín Prieto, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2019
Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced FibrosisJavier Ampuero, Raluca Pais, Rocío Aller, et al.
Digestive Diseases and Sciences|January 13, 2017
Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular CarcinomaMar Riveiro-Barciela, David Tabernero, José L Calleja, et al.
JHEP Reports : Innovation in Hepatology|October 16, 2024
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseasesEnrique García-Nieto, Juan Carlos Rodriguez-Duque, Coral Rivas-Rivas, et al.
Nature Communications|May 9, 2017
Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.
Journal of Viral Hepatitis|March 3, 2026
Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence SynthesisChristos Thomadakis, Ilias Gountas, Konstantinos Gountas, et al.
Nature Communications|June 17, 2017
Corrigendum: Hepatic p63 regulates steatosis via IKKβ/ER stressBegoña Porteiro, Marcos F Fondevila, Teresa C Delgado, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Pageof 37